Research Library
The following scientific abstracts have been reviewed by the Dr. Eliaz staff for relevance to the ingredient Modified Citrus Pectin. Click on any of the following abstract titles to see the details of the abstract.
Title: The effect of modified citrus pectin on urinary excretion of toxic elements.
Authors: Eliaz I, Hotchkiss AT, Fishman ML, Rode D.
Journal: Phytother Res. 2006 Oct;20(10):859-64.Click here to read
Title: Clinical applications of modified citrus pectin
Authors: Eliaz I.
Journal: Amitabha Medical Clinic and Healing Center, Sebastopol, CA
Title: Dietary fiber and progression of atherosclerosis: the Los Angeles Atherosclerosis Study.
Authors: Wu H, Dwyer KM, Fan Z, Shircore A, Fan J, Dwyer JH.
Journal: Am J Clin Nutr. 2003 Dec; 78(6): 1085-91.
Title: Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study.
Authors: Guess BW, Scholz MC, Strum SB, Lam RY, Johnson HJ, Jennrich RI.
Journal: Prostate Cancer Prostatic Dis. 2003;6(4):301-4.
Title: Citrus pectin and oligofructose improve folate status and lower serum total homocysteine in rats
Authors: Thoma C, Green TJ, Ferguson LR
Journal: Int J Vitam Nutr Res, 73:6, 403-9
Title: The effect of modified citrus pectin on the urinary excretion of toxic elements.
Authors: Isaac Eliaz, Dorena Rode
Journal: Fifth Annual Conference of Environmental Health Scientists: Nutritional Toxicology and Metabolomics, August 2003, University of California, Davis
Title: Effect of dietary pectin on the production of immunoglobulins and cytokines by mesenteric lymph node lymphocytes in mouse colitis induced with dextran sulfate sodium
Authors: Lim, B. O., Lee, S. H., Park, D. K., Choue, R. W.
Journal: Biosci Biotechnol Biochem, 67:8, 1706-12
Title: Modified Citrus Pectin Slows Prostate Specific Antigen Doubling Time in Men with Prostate Cancer
Authors: Brad Guess, Mark Scholz, Stephen Strum, Richard Lam, Henry Johnson, Robert Jennrich, Dorena Rode
Journal: Proceedings of the Science of the Whole Person Healing Conference March 2003 Washington D.C.
Title: Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
Authors: Bader P, Burkhard FC, Markwalder R, Studer UE.
Journal: J Urol 2003 Mar;169(3):849-54
Title: Using splines to detect changes in PSA doubling times.
Authors: Guess B, Jennrich R, Johnson H, Redheffer R, Scholz M.
Journal: Prostate 2003 Feb 1;54(2):88-94
Title: Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration.
Authors: Hittelet A, Legendre H, Nagy N, Bronckart Y, Pector JC, Salmon I, Yeaton P, Gabius HJ, Kiss R, Camby I.
Journal: Int J Cancer 2003 Jan 20;103(3):370-9
Title: Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro.
Authors: O'Driscoll L, Linehan R, Liang YH, Joyce H, Oglesby I, Clynes M.
Journal: Anticancer Res 2002 Nov-Dec;22(6A):3117-25
Title: Differential expression of galectin-3 in medullary thyroid carcinoma and C-cell hyperplasia.
Authors: Faggiano A, Talbot M, Lacroix L, Bidart JM, Baudin E, Schlumberger M, Caillou B.
Journal: Clin Endocrinol (Oxf) 2002 Dec;57(6):813-9
Title: Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin.
Authors: Nangia-Makker P, Hogan V, Honjo Y, Baccarini S, Tait L, Bresalier R, Raz A.
Journal: J Natl Cancer Inst 2002 Dec 18;94(24):1854-62
Title: Expression of human intestinal mucin is modulated by the beta-galactoside binding protein galectin-3 in colon cancer.
Authors: Dudas SP, Yunker CK, Sternberg LR, Byrd JC, Bresalier RS.
Journal: Gastroenterology 2002 Sep;123(3):817-26
Title: Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.
Authors: Lahm H, Andre S, Hoeflich A, Fischer JR, Sordat B, Kaltner H, Wolf E, Gabius HJ.
Journal: J Cancer Res Clin Oncol 2001;127(6):375-386
Title: The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium.
Authors: Glinsky VV, Glinsky GV, Rittenhouse-Olson K, Huflejt ME, Glinskii OV, Deutscher SL, Quinn TP.
Journal: Cancer Res 2001 Jun 15;61(12):4851-7
Title: Effects of daily oral administration of quercetin chalcone and modified citrus pectin.
Authors: Hayashi A; Gillen AC; Lott JR
Journal: Altern Med Rev 2000 Dec;5(6):546-52.
Title: Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties.
Authors: Matarrese P, Fusco O, Tinari N, Natoli C, Liu FT, Semeraro ML, Malorni W, Iacobelli S.
Journal: Int J Cancer 2000 Feb 15;85(4):545-54
Title: Modified Citrus Pectin Slows PSA Doubling Time: A Pilot Clinical Trial.
Authors: Stephen Strum MD, Mark Scholz MD, Jon McDermed Pharm D, Michael McCulloch BA, Isaac Eliaz MD
Journal: International Conference on Diet and Prevention of Cancer, May 1999, Tampere, Finland
Title: Modified Citrus Pectin Induces Cytotoxicity of Prostate Cancer Cells in Co-cultures with Human Endothelial Monolayers
Authors: Tania Weiss PhD, Michael McCulloch BA, Isaac Eliaz MD
Journal: International Conference on Diet and Prevention of Cancer, May 1999, Tampere, Finland
Title: Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin.
Authors: Pienta KJ, Naik H, Akhtar A, Yamazaki K, Replogle TS, Lehr J, Donat TL, Tait L, Hogan V, Raz A.
Journal: J Natl Cancer Inst 1995 Mar 1;87(5):348-53
Title: Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions.
Authors: Inohara H; Raz A
Journal: Glycoconj J 1994 Dec;11(6):527-32.
Title: Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin.
Authors: Platt D; Raz A
Journal: J Natl Cancer Inst 1992 Mar 18;84(6):438-42.
Title: Colonic bacterial flora and serum cholesterol: alterations induced by dietary citrus pectin.
Authors: Vargo D; Doyle R; Floch MH
Journal: Am J Gastroenterol 1985 May;80(5):361-4.